概括
缺氧会通过降低血管扩张剂布拉迪基宁来触发肺高血压. 抑制布拉迪基宁的无活化会阻止这种反应,这表明布拉迪基宁的存在.
科学领域:
- 肺循环 肺循环 肺循环
- 血管生理学 血管生理学
- 缺氧研究 缺氧研究
背景情况:
- 肺压力器对低氧反应的调解者仍然未被确定.
- 在诺莫克西亚期间的肺血管扩张可以通过布拉迪基宁等血管扩张剂维持.
- 布拉迪基宁在肺部用空气或氧气通风时释放出来,但很快就会被禁用.
研究的目的:
- 为了研究布拉迪基宁在肺压力器对低氧反应中的作用.
- 探索布拉迪基宁影响肺血管度的机制.
- 为了确定抑制布拉迪基宁失活是否会影响缺氧诱导的肺高血压.
主要方法:
- 研究了布拉迪基宁在肺部的释放和无活化.
- 检查了抑制布拉迪基宁失活酶对肺高血压的影响.
- 评估了血液中的布拉迪基宁的形成,膜巨细胞和粒细胞.
- 研究了氧气张力和pH对布拉迪基宁代谢的影响.
主要成果:
- 抑制不活性布拉迪基宁酶可以在慢性缺氧期间预防肺高血压.
- 颗粒细胞的布拉迪基宁的形成依赖于氧气张力.
- 勃拉迪基宁-失活酶还可以将血管素I转化为血管素II.
- 布拉迪基宁的失活率对pH值的变化很敏感.
结论:
- 在缺氧期间减少布拉迪基宁的产生可能导致肺高血压.
- 布拉迪基宁在维持肺血管度方面起着至关重要的作用.
- 勃拉迪基宁和血管激素系统之间的相互作用影响肺和全身循环.
相关概念视频
Physiological Control of Respiration
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Hyperpnea and Hyperventilation
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:


